74 related articles for article (PubMed ID: 31409916)
1. Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism.
Yamashita K; Morimoto S; Seki Y; Watanabe D; Ichihara A
Hypertens Res; 2019 Dec; 42(12):1951-1960. PubMed ID: 31409916
[TBL] [Abstract][Full Text] [Related]
2. The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study.
Brown JM; Robinson-Cohen C; Luque-Fernandez MA; Allison MA; Baudrand R; Ix JH; Kestenbaum B; de Boer IH; Vaidya A
Ann Intern Med; 2017 Nov; 167(9):630-641. PubMed ID: 29052707
[TBL] [Abstract][Full Text] [Related]
3. High-plasma soluble prorenin receptor is associated with vascular damage in male, but not female, mice fed a high-fat diet.
Visniauskas B; Reverte V; Abshire CM; Ogola BO; Rosales CB; Galeas-Pena M; Sure VN; Sakamuri SSVP; Harris NR; Kilanowski-Doroh I; Mcnally AB; Horton AC; Zimmerman M; Katakam PVG; Lindsey SH; Prieto MC
Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H762-H775. PubMed ID: 36930656
[TBL] [Abstract][Full Text] [Related]
4. Associations Between Aldosterone-Renin-Ratio and Bone Parameters Derived from Peripheral Quantitative Computed Tomography and Impact Microindentation in Men.
Holloway-Kew KL; Anderson KB; Rufus-Membere P; Tembo MC; Sui SX; Hyde NK; Kotowicz MA; Gwini SM; Yang J; Diez-Perez A; Henneberg M; Liao WH; Pasco JA
Calcif Tissue Int; 2023 Nov; 113(5):496-510. PubMed ID: 37690031
[TBL] [Abstract][Full Text] [Related]
5. Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension.
Muñoz-Durango N; Fuentes CA; Castillo AE; González-Gómez LM; Vecchiola A; Fardella CE; Kalergis AM
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347925
[TBL] [Abstract][Full Text] [Related]
6. Reduction of Proteinuria in a Patient With Primary Aldosteronism by Angiotensin II Receptor Blocker Administration.
Rikitake J; Ashida K; Miura M; Nomura M
JCEM Case Rep; 2023 Jan; 1(1):luac021. PubMed ID: 37908267
[TBL] [Abstract][Full Text] [Related]
7. Bilateral or Unilateral Aldosterone Hypersecretion and Responsiveness to Therapy are Associated with Differences in Calcium/Phosphate Homeostasis in Patients with Primary Aldosteronism.
Yarita-Kawana M; Kidoguchi S; Suehiro Y; Sugano N; Yokoo T
Intern Med; 2024 Feb; ():. PubMed ID: 38403766
[TBL] [Abstract][Full Text] [Related]
8. Low Cortisone as a Novel Predictor of the Low-Renin Phenotype.
Tapia-Castillo A; Carvajal CA; Pérez JA; Sandoval A; Allende F; Solari S; Fardella CE
J Endocr Soc; 2024 Apr; 8(6):bvae051. PubMed ID: 38586159
[TBL] [Abstract][Full Text] [Related]
9. Association between plasma aldosterone concentration and intraglomerular hemodynamics in primary aldosteronism.
Uedono H; Kurajoh M; Toi N; Tsuda A; Shinmaru K; Miki Y; Nakatani S; Nagata Y; Morioka T; Mori K; Imanishi Y; Emoto M
Am J Hypertens; 2024 May; ():. PubMed ID: 38776410
[TBL] [Abstract][Full Text] [Related]
10. Association of Elevated Serum Aldosterone Concentrations in Pregnancy with Hypertension.
Shoemaker R; Poglitsch M; Davis D; Huang H; Schadler A; Patel N; Vignes K; Srinivasan A; Cockerham C; Bauer JA; O'Brien JM
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001956
[TBL] [Abstract][Full Text] [Related]
11. Association Between Renal Sinus Fat and Cardiometabolic and Renin-Angiotensin System Parameters in Primary Aldosteronism.
Mitsuno R; Kaneko K; Nakamura T; Kojima D; Mizutani Y; Azegami T; Yamaguchi S; Yamada Y; Jinzaki M; Kinouchi K; Yoshino J; Hayashi K
J Endocr Soc; 2023 Dec; 8(1):bvad154. PubMed ID: 38116128
[TBL] [Abstract][Full Text] [Related]
12. A Case Report of Primary Aldosteronism and Extensive Hypertension-Mediated Organ Damage.
Brum de Sousa E; do Mar Menezes M; Cordeiro AM
Cureus; 2024 Feb; 16(2):e53818. PubMed ID: 38465123
[TBL] [Abstract][Full Text] [Related]
13. The mTOR-inhibitor everolimus reduces hypervolemia in patients with primary aldosteronism.
Trinh B; Burkard T
Minerva Endocrinol (Torino); 2021 Apr; ():. PubMed ID: 33792239
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Vesicles as Biomarkers and Biovectors in Primary Aldosteronism.
Neves KB; Touyz RM
Hypertension; 2019 Aug; 74(2):250-252. PubMed ID: 31230536
[No Abstract] [Full Text] [Related]
15. Cleavage of the soluble (pro)renin receptor (sATP6AP2) in the placenta.
Morosin SK; Delforce SJ; Lumbers ER; Pringle KG
Placenta; 2020 Nov; 101():49-56. PubMed ID: 32920451
[TBL] [Abstract][Full Text] [Related]
16. Soluble (pro)renin receptor promotes the fibrotic response in renal proximal tubule epithelial cells in vitro via the Akt/β-catenin/Snail signaling pathway.
Xie S; Su J; Lu A; Lai Y; Mo S; Pu M; Yang T
Am J Physiol Renal Physiol; 2020 Nov; 319(5):F941-F953. PubMed ID: 32865015
[TBL] [Abstract][Full Text] [Related]
17. Urinary soluble (pro)renin receptor excretion is associated with urine pH in humans.
Sasaki N; Morimoto S; Suda C; Shimizu S; Ichihara A
PLoS One; 2021; 16(7):e0254688. PubMed ID: 34310595
[TBL] [Abstract][Full Text] [Related]
18. (Pro)renin receptor antagonist PRO20 attenuates nephrectomy-induced nephropathy in rats via inhibition of intrarenal RAS and Wnt/β-catenin signaling.
Wang Y; Wang Y; Xue K; Wang H; Zhou J; Gao F; Li C; Yang T; Fang H
Physiol Rep; 2021 Jun; 9(11):e14881. PubMed ID: 34057312
[TBL] [Abstract][Full Text] [Related]
19. Circulating prorenin: its molecular forms and plasma concentrations.
Fujimoto K; Kawamura S; Bando S; Kamata Y; Kodera Y; Shichiri M
Hypertens Res; 2021 Jun; 44(6):674-684. PubMed ID: 33564180
[TBL] [Abstract][Full Text] [Related]
20. Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary Aldosteronism.
Watanabe D; Morimoto S; Morishima N; Kato Y; Nagashima Y; Shibata N; Ichihara A
Int J Endocrinol; 2020; 2020():9640103. PubMed ID: 33061968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
